Polymer Factory Sweden AB secures order of approx. SEK 415,000 from leading biopharmaceutical company

Polymer Factory today announces an order of significant size, as a leading biopharmaceutical company has placed an order amounting to approximately SEK 415,000.

Polymer Factory proudly announces the receipt of an order from an international biotechnology company specializing in RNA therapeutic applications. The order, amounting to approximately EUR 36,000 (SEK 415,000), includes customized dendritic nanomaterials from Polymer Factory’s innovative product portfolio. The materials purchased will be used by the customer for product development purposes, a process that holds potential for further collaboration and expanded business opportunities upon successful evaluation.

CTO Michael Malkoch comments:
“Regardless of order size, we are delighted to support our customer with highly sophisticated dendritic nanomaterials tailored for RNA applications within the life science field. This is not our first collaboration, and I remain cautiously optimistic about additional opportunities arising from this partnership”

This order marks an important milestone for Polymer Factory, reflecting the strategic value of strengthening relationships with key players in the RNA therapeutic space. It underlines the Company’s growing reputation for delivering advanced materials tailored to the evolving needs of life science innovators.

This disclosure contains information that Polymer Factory is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 09-12-2024 08:41 CET.